Aspartame prevents the karyomegaly induced by ochratoxin A in rat kidney

被引:13
作者
Baudrimont I. [1 ]
Sostaric B. [2 ]
Yenot C. [1 ]
Betbeder A.-M. [1 ]
Dano-Djedje S. [3 ]
Sanni A. [4 ]
Steyn P.S. [5 ]
Creppy E.E. [1 ]
机构
[1] Lab. de Toxicologie et d'Hygiene A., UFR des Sciences Pharmaceutiques, Université Victor Segalen, 33076 Bordeaux CEDEX
[2] Inst. for Med. Res. and Occup. Hlth., 41001 Zagreb, Ksaverska 2
[3] Faculty of Pharmacy, University of Abidjan, Abidjan
[4] Dept. de Biochim. et de Biol. Cell., FAST, Universite Natl. du Bénin, Cotonou
[5] Division of Research Development, University of Stellenbosch
关键词
Aspartame; Karyomegaly; Nephrotoxicity; Ochratoxin A; Prevention;
D O I
10.1007/s002040100229
中图分类号
学科分类号
摘要
Ochratoxin A (OTA) is a mycotoxin produced by Aspergillus ochraceus as well as other moulds. This mycotoxin contaminates animal feed and food. OTA is immunosuppressive, genotoxic, teratogenic, carcinogenic and is nephrotoxic in all animal species studied so far. OTA inhibits protein synthesis and induces lipid peroxidation. Since it seems impossible to avoid completely contamination of foodstuffs by toxigenic fungi, it is necessary to investigate the possible ways of limiting such toxicity. An attempt to prevent OTA-induced nephrotoxic and genotoxic effects, mainly the karyomegaly, has been made in vivo using aspartame (L-aspartyl-L-phenylalanine methyl ester), a structural analogue of both OTA and phenylalanine. Aspartame (25 mg/kg body weight) prevented most of the nephrotoxic effects induced by OTA (289 μg/kg body weight). It also showed some utility in preventing morphological and histological damage, mainly the karyomegaly. The protective effects of aspartame on OTA-induced nephrotoxicity could be based on several mechanisms related to competitive binding to plasma proteins, to transport or tissue distribution in the kidney or to the elimination of the toxin in the urine.
引用
收藏
页码:176 / 183
页数:7
相关论文
共 42 条
  • [1] Arora R.G., Frolen H., Interference of mycotoxins with prenatal development of the mouse. II. Ochratoxin A induced teratogenic effects in relation to the dose and stage of gestation, Acta Vet Scand, 22, pp. 535-552, (1981)
  • [2] Bacha H., Maaroufi K., Ghedira-Chekir L., Abid S., Cherif A., Achour A., Creppy E.E., Mycotoxins and mycotoxicisis in Tunisia: What do we know and what do we need to know?, J Toxicol Toxin Rev, 18, pp. 245-262, (1999)
  • [3] Baudrimont I., Betbeder A.M., Gharbi A., Pfohl-Leszkowicz A., Dirheimer G., Creppy E.E., Effect of superoxide dismutase and catalase on the nephrotoxicity induced by subchronical administration of ochratoxin A in rats, Toxicology, 89, pp. 101-111, (1994)
  • [4] Baudrimont I., Murn M., Betbeder A.M., Guilcher J., Creppy E.E., Effect of piroxicam on the nephrotoxicity induced by ochratoxin A in rats, Toxicology, 95, pp. 147-154, (1995)
  • [5] Baudrimont I., Betbeder A.M., Creppy E.E., Reduction of ochratoxin A-induced cytotoxicity in Vero cells by aspartame, Arch Toxicol, 71, pp. 290-298, (1997)
  • [6] Bauer J., Gareis M., Ochratoxin A in der nahrungsmittelkette, Z Veterinarmed B, 34, pp. 613-627, (1987)
  • [7] Belmadani A., Tramu G., Betbeder A.M., Creppy E.E., Subchronic effects of ochratoxin A on young adult rat brain and partial prevention by aspartame, a sweetener, Hum Exp Toxicol, 17, pp. 380-386, (1998)
  • [8] Berndt W., Hayes A.W., In vivo and in vitro changes in renal functions caused by ochratoxin A in the rat, Toxicology, 12, pp. 5-17, (1979)
  • [9] Bradford M.M., A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye, Anal Biochem, 72, pp. 248-254, (1976)
  • [10] Castegnaro M., Bartsch H., Chernozemsky I.N., Endemic nephropathy and urinary tract tumors in the Balkans, Cancer Res, 47, pp. 3608-3609, (1987)